SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001072613-16-000677
Filing Date
2016-02-16
Accepted
2016-02-16 17:21:57
Documents
1
Group Members
ALEXANDRA GOLLHELMUT SCHUHSLERHUBERT BIRNERSTEFAN FISCHERTVM V LIFE SCIENCE MANAGEMENT GMBH & CO. KG

Document Format Files

Seq Description Document Type Size
1 ARGOS THERAPEUTICS, INC. argos-sch13g_17908.htm SC 13G 266008
  Complete submission text file 0001072613-16-000677.txt   267740
Mailing Address 4233 TECHNOLOGY DR DURHAM NC 27704
Business Address 4233 TECHNOLOGY DR DURHAM NC 27704 9192876300
ARGOS THERAPEUTICS INC (Subject) CIK: 0001105533 (see all company filings)

IRS No.: 562110007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88006 | Film No.: 161430364
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TVM CAPITAL CORP 101 ARCH STREET SUITE 1950 BOSTON MA 02110
Business Address C/O TVM CAPITAL CORP 101 ARCH STREET SUITE 1950 BOSTON MA 02110 617-345-9320
TVM V LIFE SCIENCE VENTURES GMBH & CO KG (Filed by) CIK: 0001183073 (see all company filings)

IRS No.: 000000000
Type: SC 13G